KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 53 filers reported holding KYMERA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,414 | -68.4% | 27,296 | -47.7% | 0.00% | -71.4% |
| Q2 2023 | $1,200,584 | +137581.7% | 52,222 | +77.5% | 0.01% | +7.7% |
| Q1 2023 | $872 | +24.6% | 29,422 | +4.9% | 0.01% | -7.1% |
| Q4 2022 | $700 | -99.9% | 28,054 | +22.7% | 0.01% | +27.3% |
| Q3 2022 | $498,000 | -38.7% | 22,863 | -44.7% | 0.01% | -47.6% |
| Q2 2022 | $813,000 | -65.6% | 41,312 | -26.0% | 0.02% | -61.8% |
| Q1 2022 | $2,361,000 | +48.0% | 55,800 | +122.2% | 0.06% | +103.7% |
| Q4 2021 | $1,595,000 | +641.9% | 25,117 | +353.2% | 0.03% | +575.0% |
| Q1 2021 | $215,000 | -78.4% | 5,542 | -65.5% | 0.00% | -85.7% |
| Q4 2020 | $995,000 | -66.4% | 16,053 | -82.5% | 0.03% | -78.3% |
| Q3 2020 | $2,957,000 | – | 91,516 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |